CATHETER SITE DRYNESS

CATHETER SITE DRYNESS was reported 39 times

These drug classes are most commonly taken by patients reporting CATHETER SITE DRYNESS:

# Drug Count
0 Prostacycline Vasodilator [EPC] 28
1 Endothelin Receptor Antagonist [EPC] 19
2 Phosphodiesterase 5 Inhibitor [EPC] 15
3 Loop Diuretic [EPC] 7
4 Osmotic Laxative [EPC] 7
5 Corticosteroid [EPC] 5
6 Factor Xa Inhibitor [EPC] 5
7 Nonsteroidal Anti-inflammatory Drug [EPC] 5
8 Provitamin D2 Compound [EPC] 4
9 Aldosterone Antagonist [EPC] 3
10 Glycopeptide Antibacterial [EPC] 3
11 Platelet Aggregation Inhibitor [EPC] 3
12 Proton Pump Inhibitor [EPC] 3
13 Alkylating Drug [EPC] 2
14 Aluminum Complex [EPC] 2
15 Angiotensin 2 Receptor Blocker [EPC] 2
16 Benzodiazepine [EPC] 2
17 Cholinesterase Inhibitor [EPC] 2
18 Dietary Cholesterol Absorption Inhibitor [EPC] 2
19 Folate Analog Metabolic Inhibitor [EPC] 2
20 Nicotinic Acid [EPC] 2
21 Nitroimidazole Antimicrobial [EPC] 2
22 Non-narcotic Antitussive [EPC] 2
23 Phenothiazine [EPC] 2
24 Potassium Salt [EPC] 2
25 RNA Synthetase Inhibitor Antibacterial [EPC] 2
26 Serotonin-3 Receptor Antagonist [EPC] 2
27 Tetracycline-class Drug [EPC] 2
28 Vitamin B12 [EPC] 2
29 Vitamin C [EPC] 2
30 Vitamin D [EPC] 2
31 Antiarrhythmic [EPC] 1
32 Atypical Antipsychotic [EPC] 1
33 Barbiturate [EPC] 1
34 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1
35 Central Nervous System Stimulant [EPC] 1
36 Expectorant [EPC] 1
37 GLP-1 Receptor Agonist [EPC] 1
38 Guanylate Cyclase-C Agonist [EPC] 1
39 HMG-CoA Reductase Inhibitor [EPC] 1
40 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
41 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
42 Kinase Inhibitor [EPC] 1
43 Leukocyte Growth Factor [EPC] 1
44 Methylxanthine [EPC] 1
45 Nucleoside Metabolic Inhibitor [EPC] 1
46 P2Y12 Platelet Inhibitor [EPC] 1
47 Soluble Guanylate Cyclase Stimulator [EPC] 1
48 Thiazide Diuretic [EPC] 1
49 Thyroid Hormone Synthesis Inhibitor [EPC] 1
50 mTOR Inhibitor Immunosuppressant [EPC] 1